---
title: "康諾亞康悦達®納入國家基本醫療保險藥品目錄"
description: "康諾亞宣佈其自主研發的新藥康悦達®（司普奇拜單抗注射液）被納入《國家基本醫療保險、生育保險和工傷保險藥品目錄（2025 年）》，該目錄將於 2026 年 1 月 1 日正式實施。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/268847508.md"
published_at: "2025-12-07T05:00:21.000Z"
---

# 康諾亞康悦達®納入國家基本醫療保險藥品目錄

> 康諾亞宣佈其自主研發的新藥康悦達®（司普奇拜單抗注射液）被納入《國家基本醫療保險、生育保險和工傷保險藥品目錄（2025 年）》，該目錄將於 2026 年 1 月 1 日正式實施。

12 月 7 日，康諾亞宣佈，公司自主研發的國家 1 類新藥康悦達®（司普奇拜單抗注射液）納入《國家基本醫療保險、生育保險和工傷保險藥品目錄（2025 年）》，該目錄將自 2026 年 1 月 1 日起正式實施。

### Related Stocks

- [02162.HK - 康諾亞-B](https://longbridge.com/zh-HK/quote/02162.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Medicare Advantage's once-blistering growth dropped in 2026. Here's what that means. | Medicare Advantage's growth has slowed in 2026, with 35.5 million enrollees, a 3.2% increase from 2025, down from previo | [Link](https://longbridge.com/zh-HK/news/276639459.md) |
| Medicare Advantage's once-blistering growth dropped in 2026. Here's what that means. | Medicare Advantage's growth has slowed in 2026, with 35.5 million enrollees, a 3.2% increase from 2025, down from previo | [Link](https://longbridge.com/zh-HK/news/276521353.md) |
| Bpcl gets tax demand order worth 18.17 billion rupees | Bpcl gets tax demand order worth 18.17 billion rupees | [Link](https://longbridge.com/zh-HK/news/276594373.md) |
| FDA Dropping Requirement For 2 Studies For New Drug Approvals | The FDA has announced a significant change in its drug approval process, now allowing new drugs to be approved based on  | [Link](https://longbridge.com/zh-HK/news/276498156.md) |
| In HelloNation, Insurance Expert Ellie Mills of Boca Raton, FL Clarifies What Condo Owners Need to Know About Coverage Responsibilities | In Boca Raton, FL, insurance expert Ellie Mills clarifies the importance of personal condo insurance for owners, even if | [Link](https://longbridge.com/zh-HK/news/276548833.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。